<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02958878</url>
  </required_header>
  <id_info>
    <org_study_id>GenesysRMC</org_study_id>
    <nct_id>NCT02958878</nct_id>
  </id_info>
  <brief_title>Preoperative Administration of Tamsulosin for Prevention of Post Operative Urinary Retention in Males Undergoing Elective Inguinal Hernia Repair</brief_title>
  <official_title>Preoperative Administration of Tamsulosin for Prevention of Post Operative Urinary Retention in Males Undergoing Elective Inguinal Hernia Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Genesys Regional Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Genesys Regional Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Double blinded, randomized controlled prospective study looking at 2 preoperative doses of
      Tamsulosin an alpha-adrenergic blocker in preventing post-operative urinary retention. A
      previous study was conducted called &quot;Effectiveness of tamsulosin inprevention of
      postoperative urinary retention: a randomized double-blind-placebo controlled study&quot; This
      study involved a tertiary care center involving mostly urological surgical procedures. We
      look to specifically look at inguinal hernia surgeries in males. The aim of this study is to
      compare the prophylactic effect of tamsulosin with placebo on postoperative urinary
      retention. The drug is FDA approved for benign prostatic hypertrophy and urinary retention.
      It is on formulary at Genesys. Currently there is no standard procedure of prophylactic
      tamsulosin for urinary retention. Most often post operative patients are given tamsulosin to
      augment smooth muscle relaxation and spontaneous voiding if the patient is having urinary
      retention post operatively. We often straight catheterize patients once and start tamsulosin
      with the goal of avoiding urinary retention and future straight catheterizations or placement
      of foley catheters
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">January 3, 2017</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of Urinary Retention</measure>
    <time_frame>within 72 hours of surgery</time_frame>
    <description>If patients have urinary retention post operatively</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>placebo vs tamsulosin</measure>
    <time_frame>within 72 hours of surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Postoperative Urinary Retention</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tamsulosin 0.4mg given the night before surgery and another dose the day of surgery in the morning.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo medication given the night before surgery and another dose the day of surgery in the morning</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tamsulosin</intervention_name>
    <arm_group_label>A</arm_group_label>
    <other_name>Flomax</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Oral Capsule</intervention_name>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy males, who are not taking Tamsulosin regularly who are undergoing elective
             inguinal hernia repair (laparoscopic, open, and robotic assisted)

        Exclusion Criteria:

          -  Patients who are already taking tamsulosin, terazosin (alpha blocker treatement for
             BPH) , finasteride, dutasteride ( both 5 alpha reductase inhibitors), sulfa allergy,
             and lactose allergy
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 5, 2016</study_first_submitted>
  <study_first_submitted_qc>November 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 8, 2016</study_first_posted>
  <last_update_submitted>May 18, 2017</last_update_submitted>
  <last_update_submitted_qc>May 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Genesys Regional Medical Center</investigator_affiliation>
    <investigator_full_name>Anthony Tabatabai</investigator_full_name>
    <investigator_title>General Surgery Resident</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia, Inguinal</mesh_term>
    <mesh_term>Urinary Retention</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tamsulosin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

